About Nectero Medical
Nectero Medical is a company based in Bethlehem (United States) founded in 2019. Nectero Medical has raised $115.5 million across 3 funding rounds from investors including Boston Scientific, Norwest Venture Partners and BioStar Capital. The company has 6 employees as of December 31, 2021. Nectero Medical offers products and services including Nectero EAST System. Nectero Medical operates in a competitive market with competitors including Mercator MedSystems, PharmaIN, Samyang BioPharm, Advanced NanoTherapies and VESTECK, among others.
- Headquarter Bethlehem, United States
- Employees 6 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nectero Medical Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$115.5 M (USD)
in 3 rounds
-
Latest Funding Round
$96 M (USD), Series D
Apr 04, 2024
-
Investors
Boston Scientific
& 4 more
-
Employee Count
6
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nectero Medical
Nectero Medical offers a comprehensive portfolio of products and services, including Nectero EAST System.
Endovascular system to stabilize abdominal aortic aneurysms.
Funding Insights of Nectero Medical
Nectero Medical has successfully raised a total of $115.5M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $96 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nectero Medical
Nectero Medical has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Norwest Venture Partners and BioStar Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Locked | Locked | Locked | |
|
Healthtech startups are funded by BioStar Capital's venture capital efforts.
|
Locked | Locked | Locked | |
|
Healthcare venture capital investments are made by Cadence Healthcare Ventures.
|
Locked | Locked | Locked |
Investor details for Nectero Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nectero Medical
Investment portfolio details for Nectero Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nectero Medical
Detailed financials for Nectero Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nectero Medical Comparisons
Peer comparison for Nectero Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nectero Medical
Nectero Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mercator MedSystems, PharmaIN, Samyang BioPharm, Advanced NanoTherapies and VESTECK, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Catheter-guided microfluid injection systems are developed for targeted tissue therapies.
|
|
| Locked | Locked | Locked |
Proprietary drug delivery platforms are developed for API enhancement.
|
|
| Locked | Locked | Locked |
Transdermal drug patches and wound closure devices are developed.
|
|
| Locked | Locked | Locked |
Developer of a drug delivery device for cardiac vascular diseases
|
|
| Locked | Locked | Locked |
Developer of a device for the treatment of aortic aneurysms
|
Detailed competitors of Nectero Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nectero Medical
Complete news archive for Nectero Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nectero Medical
Nectero Medical was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Nectero Medical is headquartered in Bethlehem, United States.
Jack Springer is the current CEO of Nectero Medical.
Nectero Medical is a funded company, having raised a total of $115.5M across 3 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Nectero Medical is 6.
Nectero Medical was founded in 2019 and is headquartered in Bethlehem, United States. The company operates in the medical device sector, focusing on cardiovascular treatments. An endovascular aneurysm stabilization system is developed by the firm, through which a stabilizer agent is delivered directly to the aneurysm site. This approach is intended to reduce aneurysm growth rates and enhance aortic tissue strength. Leadership is provided by CEO Jack Springer.
Nectero Medical's top competitors include Mercator MedSystems, PharmaIN and Advanced NanoTherapies.
Nectero Medical offers Nectero EAST System.
Nectero Medical has 5 investors. Key investors include Boston Scientific, Norwest Venture Partners, BioStar Capital, Cadence Healthcare Ventures, and Aphelion Capital.